Q4 2021 13F Holders as of 12/31/2021
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
92.2M
-
Number of holders
-
15
-
Total 13F shares, excl. options
-
3.55M
-
Shares change
-
+3.19M
-
Total reported value, excl. options
-
$9.44M
-
Value change
-
+$8.49M
-
Number of buys
-
14
-
Price
-
$2.66
Significant Holders of Context Therapeutics Inc. - Common Stock, par value $0.001 per share (CNTX) as of Q4 2021
15 filings reported holding CNTX - Context Therapeutics Inc. - Common Stock, par value $0.001 per share as of Q4 2021.
Context Therapeutics Inc. - Common Stock, par value $0.001 per share (CNTX) has 15 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 3.55M shares
of 92.2M outstanding shares and own 3.85% of the company stock.
Largest 10 shareholders include SABBY MANAGEMENT, LLC (1.23M shares), AIGH Capital Management LLC (763K shares), Altium Capital Management LP (494K shares), Empery Asset Management, LP (359K shares), VANGUARD GROUP INC (215K shares), Worth Venture Partners, LLC (175K shares), Veritable, L.P. (110K shares), RENAISSANCE TECHNOLOGIES LLC (64.6K shares), Virtu Financial LLC (53.5K shares), and swisspartners Ltd. (42.2K shares).
This table shows the top 15 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.